LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 326 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17 | -19.0% | 196 | -33.3% | 0.00% | – |
| Q1 2024 | $21 | -25.0% | 294 | -25.6% | 0.00% | – |
| Q4 2023 | $28 | +21.7% | 395 | +1.0% | 0.00% | – |
| Q3 2023 | $23 | +64.3% | 391 | +105.8% | 0.00% | – |
| Q2 2023 | $14 | +7.7% | 190 | +3.8% | 0.00% | – |
| Q1 2023 | $13 | +8.3% | 183 | +4.0% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 176 | +10.7% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 159 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +27.3% | 159 | +59.0% | 0.00% | – |
| Q1 2022 | $11,000 | -47.6% | 100 | -24.8% | 0.00% | – |
| Q4 2021 | $21,000 | – | 133 | +6550.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 2 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |